Skip to content

Oncology

Oncology

Understand how a cancer care pathway is organised, why several specialties work together and which questions to discuss with the treating team.

Reading compass

Three ways to use this page

01

Understand the field

Clarify the scope of the specialty and the questions it may address.

02

Explore connected care

Move from the field to related procedures and verified public profiles.

03

Prepare a consultation

Use the page to organise questions, never to self-diagnose or select a treatment alone.

Overview

Understanding the Specialty

Cancer care starts with establishing the diagnosis and assessing the disease’s extent. Treatment planning considers the cancer type and stage, other health conditions and the person’s preferences. Depending on the situation, options may include surgery, radiotherapy, medicines or a combination; there is no single treatment for all cancers. In France, the proposal is discussed by a multidisciplinary team and then explained to the patient. Ask about the treatment’s purpose, alternatives, side effects, support and follow-up. Elysium Guide explains these steps without estimating an individual prognosis or recommending a treatment or institution.

Understand conditions within this specialty, useful context and questions to discuss with your doctor.

Related Procedures

Open a family to compare canonical procedures; technical variants and devices are explained within the relevant procedure.

Skin cancer surgery and reconstruction2
Neck, thyroid and head-and-neck oncology1
Gynaecological oncology1
Oncology, reconstruction and craniofacial1
Related Procedures16

Biopsy and pathology

A sample helps identify the disease and guide further testing. Needle sampling, endoscopy and surgery suit different circumstances. Ask about site-specific risks, anticoagulant management and the results appointment. A sample may be insufficient and need repeating. NCI

Molecular profiling and biomarkers

Tests may identify a therapeutic target or provide prognostic information. Not every test helps every cancer. A tumour result suggesting inherited susceptibility may lead to a separate cancer genetics consultation. Access to a medicine or trial is not automatic. NCI

Cancer surgery

An operation may remove a tumour, establish its extent or relieve a complication. Its scope and possible reconstruction depend on the organ. Discuss margins, function, stomas, lymph nodes and procedure-specific recovery. Surgery may take place before or after medicines or radiotherapy. NCI

Sentinel node biopsy and lymph node dissection

For selected indications, examining a first draining lymph node or removing several nodes helps assess or treat disease. These procedures are not routine for every cancer. Lymphoedema risk, sensory changes and rehabilitation measures depend on the region treated. NCI

Implanted port or central venous catheter

A venous access device facilitates some treatments and blood sampling. An implanted port and a PICC require different care. The team explains dressings, showering, maintenance and whom to contact for fever, redness, pain or arm swelling. Only trained personnel perform the intended access procedures. NCI

Cytotoxic chemotherapy

This acts on cell division and may be given through an infusion, tablets or other routes. Effects and monitoring vary by medicine, including low blood cell counts, nausea, mucosal damage or neuropathy. Oral treatment needs equal care; do not double a missed dose without instructions. NCI

Targeted therapies

These target mechanisms involved in cancer growth. Eligibility may depend on a biomarker. Skin, digestive, cardiovascular or other toxicities vary by drug. Check interactions, administration instructions and monitoring tests; “targeted” does not mean risk-free. NCI

Hormone therapy

This blocks the production or action of certain hormones in hormone-sensitive cancers, including some breast and prostate cancers. Possible effects involve hot flushes, sexuality, bones and metabolism, depending on treatment. Follow-up and duration are individualised; do not stop independently because of a side effect. NCI

Immune checkpoint inhibitors

These help the immune system act against selected cancers. Inflammation may affect several organs during or after treatment. Significant diarrhoea, breathlessness, jaundice, confusion or unusual fatigue should be reported promptly. Do not start corticosteroids independently. NCI, immune toxicities

External beam radiotherapy

Radiation is directed at a defined area after preparation and planning. Effects depend on the treated volume and may involve skin, fatigue, mucous membranes or nearby organs. External beam sessions alone do not make a person radioactive. Follow the department's skin-product and local-care instructions. NCI

Brachytherapy and systemic radioactive treatments

Brachytherapy places a source close to the target; a radiopharmaceutical may enter the circulation for certain indications. These approaches differ from external beam radiotherapy. Temporary radiation-protection instructions may concern contact with others, pregnancy or waste; the department supplies product-specific rules. NCI

Haematopoietic stem cell transplantation

Used for selected diseases, particularly blood disorders, this may use the patient's own cells or a donor's cells. The pathway includes preparation, transplantation and prolonged specialist monitoring. Infections and, with donor cells, graft-versus-host disease require dedicated instructions. NCI

CAR-T and other cellular therapies

These use immune cells for selected indications in specialist centres. The pathway may involve collection, manufacturing and preparatory treatment. Fever, low blood pressure or neurological changes may signal a serious complication; follow the centre's emergency arrangements and restrictions. NCI

Tumour ablation and interventional radiology

Image-guided techniques, such as destruction with heat or cold, can treat selected lesions. They do not suit every tumour or location. Follow-up checks local effectiveness and looks for bleeding, infection or injury to a nearby organ. NCI

Active surveillance

For selected, well-defined cancers, structured monitoring can defer treatment while preserving an opportunity to intervene. It includes planned investigations and criteria for changing strategy. It is different from no follow-up or symptom-only observation. Example: prostate, EAU

Supportive care and symptom-relieving procedures

Pain, nutrition, fatigue, anxiety and social difficulties should be addressed. Drainage, treatment of obstruction or pain-relieving radiotherapy may be proposed according to the cause. Specialist palliative care can accompany anticancer treatment; accessing it does not require stopping that treatment. NCI

Doctors

Only public profiles that have completed the required verification checks are displayed.

No verified public doctor profile is currently published for this specialty.

Healthcare Institutions

Only public institution profiles with a reviewed relationship to this specialty are displayed.

No verified public healthcare institution is currently published for this specialty.

Reference points

Official sources

Use these institutional resources to continue reading and prepare questions for a qualified professional.

Verification & Trust

Specialty pages are designed to separate editorial guidance from commercial promotion.

No rankings as a substitute for medical quality.

No paid positioning presented as clinical excellence.

No price comparison or artificial urgency.

Public guide information does not replace medical consultation.